or
forgot password
  • cancer clinical trials in bethlehem, PA

  • Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    St. Luke's Hospital and Health Network St. Luke's Cancer Network
    Bethlehem, Pennsylvania
    Advanced Neuroendocrine Tumors
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Brain and Central Nervous System Tumors
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
    Vita Hematology Oncology, P.C.
    Bethlehem, Pennsylvania 18015
    NSCLC
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    St. Luke'S Hospital & Health Network Laboratory
    Bethlehem, Pennsylvania 18015
    High Risk Stage III Melanoma
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    St. Luke'S Hospital & Health Network
    Bethlehem, Pennsylvania 18015
    Thyroid Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    St Luke's Hospital & Health Network
    Bethlehem, Pennsylvania 18015
    Melanoma
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Endometrial Cancer, Fatigue, Neurotoxicity
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Bethlehem, Pennsylvania 18015
    Diffuse Large B-Cell Lymphoma
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    St Luke'S Hospital And Health Network
    Bethlehem, Pennsylvania 18015
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Lung Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    St. Luke'S Hospital & Health Network
    Bethlehem, Pennsylvania 18015
    Malignant Melanoma
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    St Luke's Cancer Center
    Bethlehem, Pennsylvania 18015
    Peripheral T-cell Lymphoma
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Lymphoma
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    St. Luke's Hospital and Health Network St Luke's Hospital (2)
    Bethlehem, Pennsylvania
    Renal Cell Carcinoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Neuroblastoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Brain and Central Nervous System Tumors
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Brain and Central Nervous System Tumors, Neurotoxicity
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    St. Luke's Hospital and Health Network St. Luke's Cancer Network (2)
    Bethlehem, Pennsylvania
    Melanoma
    Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Metastatic Melanoma
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    St Luke'S Hospital And Health Network
    Bethlehem, Pennsylvania 18015
    Prostate Cancer
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Pancreatic Cancer
    Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Oncology Hematology of Lehigh Valley
    Bethlehem, Pennsylvania 18015
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Oncology Hematology of Lehigh Valley
    Bethlehem, Pennsylvania 18015
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Cervical Cancer
    A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy
    St. Luke's Hospital and Health Network St Luke's
    Bethlehem, Pennsylvania
    Non-small-cell Lung Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840010
    Bethlehem, Pennsylvania 18015
    Neoplasm Malignant
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Leukemia
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    St. Luke's Cancer Center Associates
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Lung
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    St. Luke's Hospital and Health Network St Luke's
    Bethlehem, Pennsylvania
    Metastatic Renal Cell Carcinoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Chronic Myeloid Leukemia
    Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors
    St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory, Approved Alternative Therapy
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma
    St. Luke's Hospital and Health Network St. Luke's Cancer Network (2)
    Bethlehem, Pennsylvania
    BRAF or NRAS Mutant Metastatic Melanoma
    A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer, Malignant Tumor of Renal Pelvis